News

Press releases

Kaltplasmatherapie

Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients

23. June 2025

23.06.2025 / 10:02 CET/CEST The issuer is solely responsible…

Business Shakehands

Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board

6. June 2025

Pinneberg, June 06, 2025 - Viromed Medical AG ("Viromed", ticker:…

Kaltplasmatherapie

Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)

15. May 2025

Study confirms the effectiveness and safety of cold plasma…

Investment

Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor

23. April 2025

Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use

10. April 2025

Pulmoplas Gerät

Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®

10. April 2025

Symbolbild Börsenkurs

Viromed Medical AG to host Medical-Roundtable to discuss EUR 152.5 million distibution agreement with Asian UMECO Group on Wednesday, April 3rd, 2025 at 1:00PM CEST

2. April 2025

Intensivpatient mit Beatmung

Viromed Medical AG reports promising study results for PulmoPlas® in intensive care unit ventilator-associated pneumonia patients

14. March 2025

Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds

6. October 2023